Revised forecast
Fiscal year ending December 2026 · Full yearPrevious forecast published 13 February 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
In the first half, results exceeded the initial forecasts due to strong performance by EHD-related products, increased sales at overseas subsidiaries, including those in China, and the contribution from the weaker yen. In the second half, the Chemicals business is expected to perform in line with the first half, while the Cosmetics business is also expected to remain solid, supported by the effects of launching new products and other factors.
| Item | Details |
|---|---|
| Net Sales | ¥58,500 million → ¥64,000 million（9.4%） |
| Operating profit | ¥4,200 million → ¥5,400 million（28.6%） |
| Ordinary income | ¥4,050 million → ¥5,400 million（33.3%） |
| Profit attributable to owners of the parent | ¥2,800 million → ¥3,800 million（35.7%） |
| Net income per share | ¥176.47 → ¥238.69 |
| Fiscal Period Covered | Fiscal year ending December 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 13 February 2026 |
| Previous-period results | Actual results for the fiscal year ended December 2025: net sales of ¥55,705 million, operating income of ¥3,847 million, ordinary income of ¥3,849 million, profit attributable to owners of the parent of ¥2,384 million, and earnings per share of ¥150.28 |
| Reason for the revision | In the first half, results exceeded the initial forecasts due to strong performance by EHD-related products, increased sales at overseas subsidiaries, including those in China, and the contribution from the weaker yen. In the second half, the Chemicals business is expected to perform in line with the first half, while the Cosmetics business is also expected to remain solid, supported by the effects of launching new products and other factors. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the first half, net sales and each profit figure exceeded the initial forecasts because EHD-related products in the Chemicals business performed well, sales at overseas subsidiaries, including those in China, increased, and the weaker yen compared with the assumptions used for the initial forecasts contributed to results. In the second half, the Chemicals business is expected to perform in line with the first half, while the Cosmetics business is also expected to remain solid, supported by the effects of launching new products and other factors.